Fluorescent Visualization in Early Oral Cancer
1 other identifier
interventional
40
1 country
1
Brief Summary
Studies from Vancouver show that fluorescent visualization (FV) is a useful method of controlling surgical margins. This early finding will now be confirmed in a national randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 1, 2014
CompletedFirst Posted
Study publicly available on registry
December 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedMay 2, 2018
May 1, 2018
6.1 years
December 1, 2014
May 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
disease specific survival
disease specific 5 year survival
5 years
Study Arms (2)
Standard Resection
ACTIVE COMPARATOROral resection will be guided by usual practice. This involves identifying the tumour with white light and then marking surgical margins and resection the primary cancer.
FV Guided Resection
EXPERIMENTALThe oral resection will be guided by fluorescent visualization (FV).
Interventions
Eligibility Criteria
You may qualify if:
- biopsy proven invasive oral cancer or severe dysplasia / Cis
- invasive cancer must be T1 or T2
- no prior history of oral cancer / treatment of oral cancer
You may not qualify if:
- prior history of oral cancer
- unable to provide informed consent
- lesion not able to be completely visualized by FV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Terry Fox Research Institutecollaborator
Study Sites (1)
Foothills Hospital
Calgary, Alberta, T2N 4N1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
December 1, 2014
First Posted
December 3, 2014
Study Start
September 1, 2011
Primary Completion
October 1, 2017
Study Completion
December 1, 2017
Last Updated
May 2, 2018
Record last verified: 2018-05